FDA issues an early warning of progressive multifocal leukoencephalopathy associated with mycophenolate mofetil and mycophenolic acid.
Q&A: How Specific GLP-1s Impact Different Patient Populations | ASHP Midyear
Jennifer Clements, PharmD, BCACP, BC-ADM, BCPS, CDCES, FADCES, FCCP, discussed current GLP-1 medication offerings and how each impacts patients differently.